Metastatic thyroid cancer unresponsive to conventional therapies: novel management approaches through translational clinical research.

Current drug targets. Immune, endocrine and metabolic disorders

Volumn 1, Issue 2, 2001, Pages 103-115

  Sarlis, N J ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; RADIOACTIVE IODINE; RETINOID;

CELL DIFFERENTIATION; DNA METHYLATION; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METASTASIS; REVIEW; THYROID TUMOR;

CELL DIFFERENTIATION; DNA METHYLATION; HISTONE DEACETYLASES; HUMANS; IODINE RADIOISOTOPES; NEOPLASM METASTASIS; RETINOIDS; THYROID NEOPLASMS;

EID: 0035428024     PISSN: 15680088     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568005310101020103     Document Type: Review

References (168)